Professor Ray Chan
@rayychan
Followers
3K
Following
17K
Media
483
Statuses
4K
@Flinders Deputy Vice-Chancellor (Research) // Professor of Cancer Care Systems and Policy // @NHMRC Investigator // Christ Believer
Joined February 2011
So, do we really know: What is a comprehensive #cancer centre? What should we expect them to be, to do, & to do for & with others? Check out Part II of our work: https://t.co/435Xoih15i
@theNCI @uicc @COSAoncology @EuropeanCancer @myESMO @ASCO @CancerCareMASCC @CancerAustralia
1
10
26
Geriatric assessment in older adults with cancer: A global scoping review of barriers and strategies to implementation https://t.co/CD0BXd9BzW via @chitchadkitchen et al @lucypgeridoc @drol007
0
4
7
Geriatric assessment in older adults with cancer: A global scoping review of barriers and strategies to implementation https://t.co/XDlKf7b51s
@chitchadkitchen @rayychan @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier
0
7
24
🚨 New #OpenAccess article! We mapped the global maze of #GeriatricAssessment in #CancerCare 🧓👵 🔍 27 barriers & 17 strategies to GA implementation ✅ Telehealth, nurse-led models, policy advocacy & more 🛠️ Tool template + upcoming #DelphiStudy Read here 👉
1
9
20
I was rejected by the Hong Kong educational system when I was 16. My score didn’t make the cut off to proceed to A-level (UK system). I then pursued education in Australia which changed my life #TweetYourRejection #medTwitter @CancerCareMASCC @fumikochino
#medTwitter #medstudentTwitter reminder: Failure is part success. Today I was organizing some papers and found these 3 #rejection letters from medical school (from Stanford, Yale, and UCSF). Normalizing rejection is just as important as sharing your wins. #tweetyourRejection
3
0
8
Pleased to have @COSAoncology endorsement of the @CancerCareMASCC and @ASCO Standards and Practice Recommendations for Advanced or Metastatic Cancer Survivorship Care: https://t.co/OyhKf58PyT. In this editorial, we offer implementation and future optimal care considerations.
1
8
29
Congratulations to all new Supportive Care 2030 Movement Fellows @CancerCareMASCC #cancer #survonc #supponc
At #MASCC25, we were pleased to congratulate our new Supportive Care 2030 Movement - President Training Fellowship recipients: @DrCCuthbert, @PotisDR, @drjhanna02, Chia Jie Tan, @DrAliqueSays, Julien Vos, and Yanfei Wang. Read more here: https://t.co/zbIYFryuKe
0
1
12
Thankful to Prof. Raymond Chan @rayychan for his generous insights during the mentorship session after my oral proffered paper at #MASCC25 His global perspective on 💰 financial toxicity in cancer care is a must-read 📖👇 📄 @JCOOP_ASCO: https://t.co/sEW3VnDQ4b
🎙️ Proud to present our work from Med Onc @OffCMCVellore at #MASCC25 Interim results of “MIND & MONEY” 💭💰 Mentors: @todrashish @JeniferJeba @askdheeraj Can we ⬇️ distress & #FinancialToxicity in pts with Stage IV cancer through structured screening + targeted referrals? 🧵👇
0
3
32
Excellent presentation by @rayychan on the benefits of navigation and the global work being done through @CancerCareMASCC with the #GINO project! Excited to see the continued evolution of this important role! #MASCC25 @oncologynursing
0
3
14
It’s an absolute honour to be recognised as a Fellow of @CancerCareMASCC - my forever professional home where I develop my research, my impact and my lifelong friendships! #fearless @Flinders #survonc #supponc
In 2025, we congratulate our inaugural cohort of MASCC Fellows. Fellow status is awarded to individuals who have made a sustained contribution to MASCC and demonstrated a continued high level of excellence in cancer supportive care practice and/or research. #MASCC25 1/3
4
0
26
Starting #MASCC with Geriatric Assessments @survonc @WilliamDale_MD 🥳 Also, thank you all for being so sporty with me selfie! #survonc #innovation
1
3
14
Excited to speak at #MASCC2025 tomorrow in the 1st plenary session @CancerCareMASCC is the preeminent international meeting on supportive care in cancer. #supponc
#FinancialToxicity: Time for a change at the global level 📆 Thursday, June 26 ⏰ 1-2:30pm PT 📍Grand III
2
8
34
There is a broad range of shark-bite mitigation measures available. If you wonder how to assess them, we’ve developed a new framework to help compare which measures might be most suitable https://t.co/lIp8rf6R38 led by Michelle Henriksen and developed with state agencies
2
4
7
Our May member newsletter is out now. Check your inbox or log into your COSA account for the latest COSA news and updates including events, opportunities, awards and recognition, peer-reviewed journal articles and useful resources. https://t.co/deqPGL078Z
0
1
2
@CancerCareMASCC @maryam_lustberg @Chaosdyna @coffeemommy @OncoAlert @rayychan @alexchan928 @AndreasC466 @Joanne_Bowen_ @hannahrwardill We would like to inform you that your post has been published on OncoDaily. Thank you for sharing https://t.co/uxriApwq4S
oncodaily.com
MASCC25 “Partnering with Patients in Managing Chronic Toxicities of Cancer and Its Treatment” Workshop / cancer, Maryam Lustberg, MASCC, MASCC25, OncoDaily,
0
1
5
People with advanced or metastatic cancer have significant unmet needs. Our joint standards and recommendations w/ @CancerCareMASCC aim to improve quality of survivorship care. Clinicians can take immediate steps to address these needs: https://t.co/slDh1Wqd2G
#ASCOEdBook
2
21
35
Join Beyond Survivorship 101: Building Advanced Skills in Survivorship Care Workshop at MASCC25 @CancerCareMASCC @DrN_CancerPCP @DarcyBurbage
https://t.co/xORzRJaejF
#Cancer #CancerSurvivorship #SurvivorshipCare #Workshop #MASCC25 #Medicine #Health #MedX #MedNews #MedEd
0
1
15
Our #MASCC25 workshop “Beyond Survivorship 101: Building Advanced Skills in Survivorship Care” will be chaired by Prof Michael Jefford & @DrN_CancerPCP with additional speaker Dr @DarcyBurbage. Learn more and see all workshops here: https://t.co/2oOZskbRHs
#SuppOnc #SurvOnc
1
7
13
MASCC is pleased to endorse “Fast Facts: Biosimilars: A Global Perspective” from @KargerPublisher. This resource is intended to help healthcare decision-makers determine the value of biosimilars in clinical practice and aid discussions with patients. https://t.co/I0dFtaGuek
0
2
3